101 related articles for article (PubMed ID: 7530509)
1. Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines.
Kitayama H; Kanakura Y; Furitsu T; Tsujimura T; Oritani K; Ikeda H; Sugahara H; Mitsui H; Kanayama Y; Kitamura Y
Blood; 1995 Feb; 85(3):790-8. PubMed ID: 7530509
[TBL] [Abstract][Full Text] [Related]
2. Cryo-EM analyses of KIT and oncogenic mutants reveal structural oncogenic plasticity and a target for therapeutic intervention.
Krimmer SG; Bertoletti N; Suzuki Y; Katic L; Mohanty J; Shu S; Lee S; Lax I; Mi W; Schlessinger J
Proc Natl Acad Sci U S A; 2023 Mar; 120(13):e2300054120. PubMed ID: 36943885
[TBL] [Abstract][Full Text] [Related]
3. Physiological and regenerative functions of sterile-α motif protein-14 in hematopoiesis.
Schaefer MA; Roy P; Chava S; Meyerson A; Duncan AL; Chee L; Hewitt KJ
Exp Hematol; 2023 Dec; 128():38-47. PubMed ID: 37722652
[TBL] [Abstract][Full Text] [Related]
4. 'Youthful' phenotype of c-Kit
Firouzi F; Echeagaray O; Esquer C; Gude NA; Sussman MA
Cell Mol Life Sci; 2022 Jul; 79(8):424. PubMed ID: 35841449
[TBL] [Abstract][Full Text] [Related]
5. c-Kit Receptors as a Therapeutic Target in Cancer: Current Insights.
Abdellateif MS; Bayoumi AK; Mohammed MA
Onco Targets Ther; 2023; 16():785-799. PubMed ID: 37790582
[TBL] [Abstract][Full Text] [Related]
6. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors.
Hirota S; Isozaki K; Moriyama Y; Hashimoto K; Nishida T; Ishiguro S; Kawano K; Hanada M; Kurata A; Takeda M; Muhammad Tunio G; Matsuzawa Y; Kanakura Y; Shinomura Y; Kitamura Y
Science; 1998 Jan; 279(5350):577-80. PubMed ID: 9438854
[TBL] [Abstract][Full Text] [Related]
7. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.
Furitsu T; Tsujimura T; Tono T; Ikeda H; Kitayama H; Koshimizu U; Sugahara H; Butterfield JH; Ashman LK; Kanayama Y
J Clin Invest; 1993 Oct; 92(4):1736-44. PubMed ID: 7691885
[TBL] [Abstract][Full Text] [Related]
8. Immortalized erythroid cells as a novel frontier for in vitro blood production: current approaches and potential clinical application.
Cervellera CF; Mazziotta C; Di Mauro G; Iaquinta MR; Mazzoni E; Torreggiani E; Tognon M; Martini F; Rotondo JC
Stem Cell Res Ther; 2023 May; 14(1):139. PubMed ID: 37226267
[TBL] [Abstract][Full Text] [Related]
9. CRISPR/Cas9-engineering of HMC-1.2 cells renders a human mast cell line with a single D816V-KIT mutation: An improved preclinical model for research on mastocytosis.
Bandara G; Falduto GH; Luker A; Bai Y; Pfeiffer A; Lack J; Metcalfe DD; Olivera A
Front Immunol; 2023; 14():1078958. PubMed ID: 37025992
[TBL] [Abstract][Full Text] [Related]
10. Recent Advances in the Molecular Biology of Systemic Mastocytosis: Implications for Diagnosis, Prognosis, and Therapy.
Martelli M; Monaldi C; De Santis S; Bruno S; Mancini M; Cavo M; Soverini S
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32498255
[TBL] [Abstract][Full Text] [Related]
11. Bioisosteric Discovery of NPA101.3, a Second-Generation RET/VEGFR2 Inhibitor Optimized for Single-Agent Polypharmacology.
Moccia M; Frett B; Zhang L; Lakkaniga NR; Briggs DC; Chauhan R; Brescia A; Federico G; Yan W; Santoro M; McDonald NQ; Li HY; Carlomagno F
J Med Chem; 2020 May; 63(9):4506-4516. PubMed ID: 32298114
[TBL] [Abstract][Full Text] [Related]
12. Relationship between diagnostic imaging features and prognostic outcomes in gastrointestinal stromal tumors (GIST).
Danti G; Addeo G; Cozzi D; Maggialetti N; Lanzetta MM; Frezzetti G; Masserelli A; Pradella S; Giovagnoni A; Miele V
Acta Biomed; 2019 Apr; 90(5-S):9-19. PubMed ID: 31085970
[TBL] [Abstract][Full Text] [Related]
13. Context-dependent regulation of receptor tyrosine kinases: Insights from systems biology approaches.
Lam I; Pickering CM; Mac Gabhann F
Wiley Interdiscip Rev Syst Biol Med; 2019 Mar; 11(2):e1437. PubMed ID: 30255986
[TBL] [Abstract][Full Text] [Related]
14. Detection of
Emelyanova M; Ghukasyan L; Abramov I; Ryabaya O; Stepanova E; Kudryavtseva A; Sadritdinova A; Dzhumakova C; Belysheva T; Surzhikov S; Lyubchenko L; Zasedatelev A; Nasedkina T
Oncotarget; 2017 Aug; 8(32):52304-52320. PubMed ID: 28881731
[TBL] [Abstract][Full Text] [Related]
15. Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells.
Abbaspour Babaei M; Kamalidehghan B; Saleem M; Huri HZ; Ahmadipour F
Drug Des Devel Ther; 2016; 10():2443-59. PubMed ID: 27536065
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous mastocytosis with a mutation in the juxtamembrane domain of c-kit in a young laboratory beagle dog.
Kato Y; Kashiwagi E; Masuno K; Fujisawa K; Tsuchiya N; Matsushima S; Torii M; Takasu N
J Toxicol Pathol; 2016 Jan; 29(1):49-52. PubMed ID: 26989302
[TBL] [Abstract][Full Text] [Related]
17. Detection of novel polymorphisms in the ckit gene of canine patients with lymphoma, melanoma, haemangiosarcoma, and osteosarcoma.
Gramer I; Kessler M; Geyer J
Vet Res Commun; 2016 Jun; 40(2):89-95. PubMed ID: 26971271
[TBL] [Abstract][Full Text] [Related]
18. Nuclear AURKA acquires kinase-independent transactivating function to enhance breast cancer stem cell phenotype.
Zheng F; Yue C; Li G; He B; Cheng W; Wang X; Yan M; Long Z; Qiu W; Yuan Z; Xu J; Liu B; Shi Q; Lam EW; Hung MC; Liu Q
Nat Commun; 2016 Jan; 7():10180. PubMed ID: 26782714
[TBL] [Abstract][Full Text] [Related]
19. Neutralization of KIT Oncogenic Signaling in Leukemia with Antibodies Targeting KIT Membrane Proximal Domain 5.
Le Gall M; Crépin R; Neiveyans M; Auclair C; Fan Y; Zhou Y; Marks JD; Pèlegrin A; Poul MA
Mol Cancer Ther; 2015 Nov; 14(11):2595-605. PubMed ID: 26358753
[TBL] [Abstract][Full Text] [Related]
20. Identification of Novel Small Molecule Inhibitors of Oncogenic RET Kinase.
Moccia M; Liu Q; Guida T; Federico G; Brescia A; Zhao Z; Choi HG; Deng X; Tan L; Wang J; Billaud M; Gray NS; Carlomagno F; Santoro M
PLoS One; 2015; 10(6):e0128364. PubMed ID: 26046350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
